MIMEDX Announces Second Quarter 2022 Operating and Financial Results
August 02, 2022 16:05 ET
|
MiMedx Group, Inc
Second Quarter Net Sales of $66.9 Million Reflects Double-Digit Revenue Increase for the Fourth Consecutive Quarter in the Company's Continuing Portfolio of Products Achieves Strong Year-Over-Year...
MIMEDX Announces Formation of Regenerative Medicine Scientific Advisory Board Comprised of Renowned Industry and Academic Experts
July 27, 2022 08:00 ET
|
MiMedx Group, Inc
Scientific Advisory Board Adds Multi-disciplinary Clinical and Scientific Expertise to Support Acceleration of the Company’s mdHACM Placental Biologics Pipeline MARIETTA, Ga., July 27, 2022 (GLOBE...
MIMEDX to Host Second Quarter 2022 Operating and Financial Results Conference Call on August 3
July 20, 2022 08:00 ET
|
MiMedx Group, Inc
MARIETTA, Ga., July 20, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that it will report...
MIMEDX Welcomes Kate Surdez as Chief Human Resources Officer
July 18, 2022 09:35 ET
|
MiMedx Group, Inc
Proven Biotech Executive Brings Versatile Leadership Experience MARIETTA, Ga., July 18, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational...
MIMEDX Engages Nordic Bioscience Clinical Development A/S to Propel Registrational Trials of Placental Biologic Injectable for Knee Osteoarthritis
June 15, 2022 08:30 ET
|
MiMedx Group, Inc
Image Analysis Group to Provide Imaging Strategy and Advanced Imaging Analytics in Support of MIMEDX’s Knee Osteoarthritis Clinical Trial Program MARIETTA, Ga., June 15, 2022 (GLOBE NEWSWIRE) --...
MIMEDX Shareholders Vote to Approve All Proposals at the 2022 Annual Meeting
June 07, 2022 16:05 ET
|
MiMedx Group, Inc
Dr. Phyllis Gardner and James L. Bierman Reelected to Board of Directors Company Also Receives Approvals for Say-on-Pay Proposal and Qualified Employee Stock Purchase Plan MARIETTA, Ga., June 07,...
MIMEDX Reminds Shareholders to Pre-Register for the Upcoming Virtual 2022 Annual Meeting of Shareholders
June 03, 2022 08:00 ET
|
MiMedx Group, Inc
Deadline to Pre-Register is 9:00 a.m. Eastern Time on June 6, 2022 Pre-Registration Required to Attend Annual Meeting Visit www.votemimedx.com for Instructions on How to Pre-Register MARIETTA,...
MIMEDX Addresses Presentation by Prescience Point
June 02, 2022 08:03 ET
|
MiMedx Group, Inc
Company Highlights Factually Accurate Information Already Provided Urges Shareholders to Vote “FOR” MIMEDX’s Highly Qualified and Independent Directors – James L. Bierman and Phyllis Gardner, M.D. On...
MIMEDX Board Chair Dr. M. Kathleen Behrens Writes Letter to Fellow Shareholders
May 31, 2022 16:05 ET
|
MiMedx Group, Inc
Urges Shareholders to Vote “FOR” MIMEDX’s Highly Qualified and Independent Directors – James L. Bierman and Phyllis Gardner, M.D. on the WHITE Proxy Card Today MARIETTA, Ga., May 31, 2022 ...
MIMEDX Receives $4.6 Million Award from the Department of Defense to Advance the Treatment of Combat Casualty Wounds and Burns
May 31, 2022 08:00 ET
|
MiMedx Group, Inc
Funding Enables Evaluation of PURION® Processed Placental Tissue as an Innovative Approach in the Management of Acute Military-Related Injuries, Addressing a Critical Unmet Need MARIETTA, Ga., May ...